Background: The imaginative power of a human patient has the big advantage of sourcing his/her own depth leading to first-hand experiencing. Such experiences have a potential to make a deep impact that can be instrumental to the process of healing. Successful healing is almost inevitably linked to new recognitions and perceptions, changes in attitudes or changes in lifestyle. Therapists in charge may find that they cannot exert direct control over this process but nevertheless, there is a big inherent potential to such processes as a truly complementary approach to clinical oncology. Case Reports: Going by the characteristic of the matter, it seems impossible to conduct randomized trials; rather, we have to learn from the very individual experiences and try to find common traits. Hence, in this contribution, it is “just” three cases that are presented: patients with a pancreatic tumor, lung metastasis, and a colon carcinoma. Still, the same objectives of evaluation criteria as in any conventional clinical trial, namely overall survival and quality of life, are followed here. The presented cases are set against expected outcomes of the guideline-oriented therapy options. Conclusion: Quality of life has improved in all three cases, expected overall survival extended in one case, the second is still to be verified. Certainly beneficially, however, is the ratio of effect to – in these cases – no negative side effects.

1.
Schmid
GB
.
Selbstheilung durch Vorstellungskraft
.
Springer-Wien
;
2010
.ISBN: 978-3-7091-0157-5.
2.
Dispenza
J
.
You are the Placebo. Hayhouse
.
UK ISBN
;
2014
.ISBN: 978-1-78180-257-1.
3.
Simonton
OC
,
Metthew-Simonton
S
,
Creighton
J
. (
1978
). Getting well again. J.P.Tarcher, Los Angeles. ISBN 0-87477-070-X
4.
Erstling
T
.
Krebs mit inneren Bildern behandeln
.
Param Verlag, Ahlersted
;
2011
.ISBN: 978-3-88755-278-7.
5.
American Cancer Society
(
1981
) CA-A CANCER JOURNAL FOR CLINICIANS, June issue
6.
Kekecs
Z
,
Varga
K
.
Positive suggestion techniques in somatic medicine: A review of the empirical studies
.
Interv Med Appl Sci
.
2013
Sep
;
5
(
3
):
101
11
.
[PubMed]
2061-1617
7.
Varga
K
.
Suggestive techniques connected to medical interventions
.
Interv Med Appl Sci
.
2013
Sep
;
5
(
3
):
95
100
.
[PubMed]
2061-1617
8.
Varga
K
,
Varga
Z
,
Fritúz
G
.
Psychological support based on positive suggestions in the treatment of a critically ill ICU patient - A case report
.
Interv Med Appl Sci
.
2013
Dec
;
5
(
4
):
153
61
.
[PubMed]
2061-1617
9.
Sabine Fruth is a pioneer on imagined body travel. There is a publication announced however oral presentations are already available: https://www.sabine-fruth.de/ikr.php
10.
Jensen
MP
,
Adachi
T
,
Hakimian
S
(
2015
). Brain Oscillations, Hypnosis, and Hypnotizability. Am J Clin Hypn. Jan;57(3):230-53. doi: .
11.
Kihlstrom
JF
.
Neuro-hypnotism: prospects for hypnosis and neuroscience
.
Cortex
.
2013
Feb
;
49
(
2
):
365
74
.
[PubMed]
0010-9452
12.
Ray
WJ
.
EEG concomitants of hypnotic susceptibility
.
Int J Clin Exp Hypn
.
1997
Jul
;
45
(
3
):
301
13
.
[PubMed]
0020-7144
13.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer Statistics, 2017
.
CA Cancer J Clin
.
2017
Jan
;
67
(
1
):
7
30
.
[PubMed]
0007-9235
14.
Suker
M
,
Beumer
BR
,
Sadot
E
, et al.
.
A patient-level meta- analysis of FOLFIRINOX for locally advanced pancreatic cancer
.
Lancet Oncol
.
2016
;
17
:
801
10
.
[PubMed]
1470-2045
15.
Association for Regression and reincarnation Research (
2018
); webpage-chapter on Womb Regression https://www.arrrglobal.org/womb-regression
16.
Re-Living Birth and Before: Birth Trauma In the Regression Therapies (
2018
);
17.
Behrmann
I
,
Sturm
M
.
Leben und Geburt
.
Heidelberg
:
Regressionstherapeutische Dokumente. Mattes Verlag
;
2008
.ISBN: 978-3-86809-012-3.
18.
Hepper
PG
. (
1996
). Fetal memory: Does it exist? What does it do? Acta Paediatr 1996; Suppl 416:16-20. Stockholm. ISSN 0803-5326
19.
Cheek
DB
(
1986
). Prenatal and perinatal imprints: Apparent prenatal consciousness as revealed by hypnosis. Pre- and Perinatal Psychology Journal 1(2), 97-110
20.
Goldstein
D
,
El-Maraghi
RH
,
Hammel
P
,
Heinemann
V
,
Kunzmann
V
,
Sastre
J
, et al.
.
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial
.
J Natl Cancer Inst
.
2015
Jan
;
107
(
2
):
dju413
.
[PubMed]
0027-8874
21.
Von Hoff
DD
,
Ervin
T
,
Arena
FP
,
Chiorean
EG
,
Infante
J
,
Moore
M
, et al.
.
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
.
N Engl J Med
.
2013
Oct
;
369
(
18
):
1691
703
.
[PubMed]
0028-4793
22.
Conroy
T
,
Desseigne
F
,
Ychou
M
,
Bouché
O
,
Guimbaud
R
,
Bécouarn
Y
, et al.;
Groupe Tumeurs Digestives of Unicancer
;
PRODIGE Intergroup
.
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
.
N Engl J Med
.
2011
May
;
364
(
19
):
1817
25
.
[PubMed]
0028-4793
23.
Burris
HA
3rd
,
Moore
MJ
,
Andersen
J
,
Green
MR
,
Rothenberg
ML
,
Modiano
MR
, et al.
.
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
.
J Clin Oncol
.
1997
Jun
;
15
(
6
):
2403
13
.
[PubMed]
0732-183X
24.
Stewart
D
,
Yan
Y
,
Mutch
M
,
Kodner
I
,
Hunt
S
,
Lowney
J
, et al.
.
Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy
.
Colorectal Dis
.
2008
Nov
;
10
(
9
):
879
86
.
[PubMed]
1462-8910
25.
Aaronson
NK
,
Ahmedzai
S
,
Bergman
B
,
Bullinger
M
,
Cull
A
,
Duez
NJ
, et al.
.
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
.
J Natl Cancer Inst
.
1993
Mar
;
85
(
5
):
365
76
.
[PubMed]
0027-8874
You do not currently have access to this content.